NCT06029257View on ClinicalTrials.gov

A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

RecruitingOBSERVATIONAL

Enrollment

110

Participants

Timeline

Start Date

November 14, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Genital Psoriasis

Interventions

DRUG

Tildrakizumab

As provided in real-world clinical practice.

Trial Locations (1)

8020

RECRUITING

Medizinische Universität Graz, Graz

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Almirall, S.A.

INDUSTRY